openPR Logo
Press release

Life Science Instrumentation Market to Rake in Nearly US$85.1 bn In Terms of Revenue By the End of 2022

12-05-2017 11:29 AM CET | Health & Medicine

Press release from: Transparency Market Research

Life Science Instrumentation Market to Rake in Nearly US$85.1 bn

The global life science instrumentation market is likely to exhibit a steady growth trajectory in the coming years due to the rapid growth of key application sectors such as the healthcare sector as well as the rising diversity of applications of the life sciences sector. The life sciences sector has taken on an important role due to the increasing amount of information being gathered about human health and the various factors that interact with it. The increasing effort to understand the genomic background of health issues is also likely to benefit the global life science instrumentation market in the coming years.

According to Transparency Market Research, the global life science instrumentation market was valued at US$57.4 bn in 2017 and is likely to rise to US$85.1 bn by 2022, exhibiting a robust 8.2% CAGR therein.

Read Report @ https://www.transparencymarketresearch.com/life-science-instrumentation-market.html

Here are the key insights into the growth prospects of the life science instrumentation market:

The growing government support to the life sciences sector is the prime driver for the global life science instrumentation market. The rising support for scientific progress has seen the life sciences sector become a key beneficiary of government resources in developed countries, while a number of developing countries have also been vital in the development of the global life sciences sector in recent years. The increasing support provided to the healthcare industry by growth of the life sciences sector is likely to enable rapid progress of the life sciences sector in the coming years, thus aiding growth of the global life science instrumentation market.

The growing biotech sector is also vital for the global life science instrumentation market. Biotech companies are major end users of life science instrumentation due to the vital need for life science innovations in biotech development, and rising investment in the biotech sector is thus likely to aid the growth of the life science instrumentation market in the coming years.

Spectrometry is likely to be the dominant technique in use in the global life science instrumentation market. Spectrometry is used in healthcare as well as food and beverage applications to detect the presence of contaminants and the growing demand from both industries is likely to enable steady growth in demand for spectrometry technology and devices in the coming years. Spectrometry accounted for 29.4% of the global life science instrumentation market in 2017, with a valuation of US$19.2 bn, and is likely to rise to a valuation of US$28.4 bn by 2022 at a CAGR of 8.2% therein. The absolute growth of the spectrometry segment is likely to be higher than any other technique segment of the global life science instrumentation market.

North America and Europe are likely to be the dominant regional contributors to the global life science instrumentation market in the coming years due to the strong government support to the life sciences sector in developed regions such as the U.S., Canada, and Western Europe. The North America and Europe markets for life science instrumentation are likely to rise to a valuation of US$28 bn and US$23.4 bn, respectively, by 2022.

Asia Pacific countries such as China are also likely to play a key role in development of the global life science instrumentation market in the coming years due to the rising realization of the utility of the life sciences sector in improving the indigenous healthcare sector and the high commercial potential oft eh sector. The APEJ market is thus likely to exhibit the highest CAGR of 8.6% over the 2017-2022 forecast period and is expected to rise to a valuation of US$19.2 bn by 2022.

Competitive Dynamics

Key players profiled in the report include Becton, Dickinson, and Company, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Perkinelmer Inc., GE Healthcare, Merck KGaA, Bruker Corporation, Hitachi High-Technologies Corporation, Eppendorf AG, and Shimadzu Corporation.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=16265

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. 

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Life Science Instrumentation Market to Rake in Nearly US$85.1 bn In Terms of Revenue By the End of 2022 here

News-ID: 845410 • Views:

More Releases from Transparency Market Research

Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion by 2036, Driven by Rising Opioid Use and Targeted Therapies
Global Opioid Induced Constipation Treatment Market Set to Reach USD 5.2 Billion …
The global opioid induced constipation (OIC) treatment market is witnessing steady and sustained growth as healthcare systems worldwide place increasing emphasis on comprehensive pain management and supportive care. Valued at US$ 2.9 billion in 2025, the market is projected to reach US$ 5.2 billion by 2036, expanding at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2036. Growth is primarily fueled by the rising prevalence of chronic
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product Type / By Impact Frequency | China • India • Japan • U.S.
Pneumatic Flux Chipper Market Expanding at 7.4% CAGR Through 2036 - By Product T …
The global Pneumatic Flux Chipper Market is set to witness sustained and resilient growth over the next decade, underpinned by expanding heavy manufacturing activities, rising welding and fabrication demand, and continuous investments in industrial infrastructure across emerging and developed economies. According to the latest industry analysis, the market was valued at US$ 760.5 Mn in 2025 and is projected to reach US$ 1,680.8 Mn by 2036, expanding at a compound
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Billion in 2025 to US$ 244.4 Billion at 27% CAGR
AI in Automotive Market Outlook 2036: Global Industry to Surge from US$ 19.8 Bil …
The AI in automotive market is entering a phase of exponential expansion, supported by rapid digitization of vehicles, growing safety mandates, and consumer demand for intelligent mobility. The global market was valued at US$ 19.8 Bn in 2025 and is projected to reach US$ 244.4 Bn by 2036, registering a remarkable CAGR of 27% from 2026 to 2036. This growth trajectory reflects the transition of automobiles from mechanically driven products to
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable Drug Demand
Hypodermic Needles Market to Reach US$ 7.9 Billion by 2036 on Rising Injectable …
The global hypodermic needles market was valued at approximately US$ 4.2 billion in 2025 and is projected to reach around US$ 7.9 billion by 2036, expanding at a CAGR of nearly 5.8% from 2026 to 2036, driven by the rising prevalence of diabetes, cancer, and chronic diseases, growing demand for injectable drugs and biologics, and the expansion of global vaccination and immunization programs; increasing adoption of safety-engineered and disposable needles,

All 5 Releases


More Releases for US$85

07-02-2024 | Food & Beverage
Fact.MR
Flavored Syrup Market Is Predicted To Expend US$ 85 Billion By 2033
The flavored syrup market is on a remarkable growth trajectory, projected to expand from a valuation of $52 billion in 2023 to an impressive $85 billion by 2033. This significant growth is driven by various factors, including evolving consumer preferences, the rise of innovative flavors, and the increasing application of flavored syrups across different sectors. Within this market, fruit-flavored syrups are particularly prominent, expected to hold a substantial 40% share.
03-19-2024 | Food & Beverage
Fact.MR
Flavored Syrup Market Forecasted to Achieve US$ 85 Billion by 2033
The global flavored syrup market (Pasar Sirap Berperisa) is predicted to increase at a 5% CAGR from US$ 52 billion in 2023 to US$ 85 billion by the end of 2033. The flavoured syrup market is a dynamic section of the food and beverage industry that caters to consumers' various tastes and preferences for sweetened beverages and culinary creations. Flavoured syrups, which come in a wide range of flavours from classic
Biosimilars Market To Reach US$ 85 Bn in 2031
The Global Biosimilars Market is estimated to attain a valuation of US$ 85 Bn by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 15.5% during the forecast period, 2022-2031. The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of the
Biosimilars Market to Reach More than US$ 85 Bn by 2031
Biosimilars Market Outlook 2031 • The global biosimilars market was valued at US$ 20.4 Bn in 2021 • The global market is expected to advance at a CAGR of 15.5% from 2022 to 2031 • The global biosimilars market is anticipated to reach more than US$ 85 Bn by the end of 2031 Report Overview: https://www.transparencymarketresearch.com/biosimilars-market.html Overview of Biosimilars Market Biosimilar can be defined as a biologic medical product, which is considered very similar to an already-approved biologic. These
Sterilization Wrap Market Forecasted to Reach US$85 million by 2026
The global sterilization wrap market features a competitive landscape in which various players are competing against one another on the basis of advanced products they are offering that come with an array of features, notes Transparency Market Research (TMR). Several players are engaged in developing sterilization wraps with better materials that promise increased bacterial filtration efficiency for a wide range of airborne and waterborne contamination, to consolidate their positions in
Portable Tools Market Projected to Reach US$ 85 Billion By 2028
Portable tools market continues to maintain its momentum on back of strong sales of personal protective equipment and power tools. The US$ 85 billion market is likely to show Goldilocks growth, with market revenues likely to grow by 1.4X between 2018 and 2028. These insights are according to a latest Fact.MR study that tracks the portable tools market in over seven regions and over 50 countries. According to the report, the